'You're playing with fire': Damning study indicates Merck & Co.'s COVID-19 drug Lagevrio is responsible for new mutations of the virus in patients
Merck & Co.'s COVID-19 pill Lagevrio may be helping to generate and spread new variants, according to a new study. These mutant spin-offs could possibly turn out to be potentially more contagious and deadly than the virus the drug was originally supposed to combat.
What's the background?
Molnupiravir, sold as Lagevrio, is an antiviral drug from Merck & Co. and Ridgeback Biotherapeutics. It is supposed to prevent RNA viruses from replicating by inducing mutations in the virus genome during replication. The National Institutes of Health claimed that this pill had "shown antiviral activity against SARS-CoV-2 in vitro and in clinical trials."---More...
Welcome to CFP’s Comment Section!
The Comment section of online publications is the new front in the ongoing Cancel Culture Battle.
Big Tech and Big Media are gunning for the Conservative Voice—through their Comment Sections.
Canada Free Press wishes to stay in the fight, and we want our fans, followers, commenters there with us.
We ask only that commenters keep it civil, keep it clean.
Thank You for your patience and for staying aboard the CFP ‘Mother Ship’.
READ OUR Commenting Policy